HIV and AIDS

This guide underscores the importance of HIV testing and immediate treatment upon diagnosis to reduce new infections. With over 1 million individuals in the US unaware of their HIV status, early detection is vital. Health care providers play a critical role by conducting routine screenings, linking those diagnosed with HIV to treatment and prevention services, and providing preventive measures like pre-exposure prophylaxis (PrEP) to those at risk.

Helpful tips for having successful conversations about HIV prevention, testing, and treatment with friends, family, and other loved ones.

The aim of this legal research is to compile enacted state laws and regulations regarding reporting requirements for negative HIV and Hepatitis C test results. The research includes all 50 states as well as the District of Columbia and only covers enacted laws and regulations – excluding proposed bills, sub-regulatory guidance, and case law.  Reporting requirements for a specific jurisdiction may vary between health care providers and clinical laboratories. Data displayed within this map excludes provisions specific to prenatal/postnatal testing and exposed newborns – infants.

NASTAD intends for health department staff to use this slide deck as a template to present foundational cluster detection and response (CDR) information to community partners and health department staff, either in-person or virtually. Slides, accompanying notes, and slide animations should be adapted based on factors including the audience, details regarding the jurisdiction's CDR work, and state/local policies. We recommend consulting your health department’s legal counsel for expertise and assistance with the section on state HIV criminalization laws.
 

In this second webinar of a three-part series, "Addressing Priorities in HIV Testing", panelists shared experiences implementing HIV prevention and care in sexual health clinics.

The newly released study by The AIDS Institute examines the individual insurance plans available for 2024 in the 32 states and Washington, DC without legislation restricting use of CAAPs.

AHEAD is "one tool" supporting and/or tracking the Ending the HIV Epidemic in the U.S. (EHE). AHEAD helps track the six EHE indicators in areas with the highest burden of HIV. It complements and serves as one of many important implementation elements of the EHE initiative and the National HIV/AIDS Strategy. This interactive dashboard can be used to inform planning and is a starting place to explore other HIV data sources.

This webpage from Texas Health and Human Services discusses HIV in women. This webpage offers various infographics, sharable graphics, and fast facts on HIV in women.

Controlling prescription drug expenditures is a priority for all state and territorial ADAPs providing antiretrovirals and other essential medications to uninsured and underinsured people with HIV. Indeed, good stewardship of federal funds requires ADAPs to acquire and pay for drugs in the most economical manner feasible.

PrEP (pre-exposure prophylaxis) is medicine people take to prevent getting HIV from sex or injection drug use. This video provides information about PrEP.